Related Experiment Video

Updated: Jul 13, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Metabolic mechanisms of cancer-induced inhibition of immune responses

Antonella Viola1, Vincenzo Bronte

  • 1Venetian Institute of Molecular Medicine, Padua, Italy; Istituto Clinico Humanitas IRCCS, Via Manzoni 56, 20089 Rozzano, Milan, Italy. antonella.viola@unipd.it

Seminars in Cancer Biology
|July 27, 2007
PubMed

Insights

Tumors evade immune attack by altering metabolism of key nutrients like arachidonic acid and amino acids. Understanding these metabolic changes offers new therapeutic targets to restore anti-cancer immune responses.

Area of Science:

  • Immunology
  • Cancer Biology
  • Metabolic Pathways

Background:

  • Tumor progression often leads to immune evasion.
  • The tumor microenvironment significantly alters host metabolism.
  • Dysregulation of arachidonic acid and amino acid metabolism impacts immune cells.

Purpose of the Study:

  • To investigate how tumor microenvironment-induced metabolic changes affect immune cells.
  • To identify novel therapeutic targets for overcoming cancer-induced immune suppression.

Main Methods:

  • Analysis of metabolic alterations in the tumor microenvironment.
  • Assessment of immune cell function in relation to metabolic changes.
  • Exploration of pharmacological interventions targeting metabolic pathways.

Main Results:

  • Tumor progression is associated with significant metabolic reprogramming.
  • Altered metabolism of arachidonic acid and amino acids (l-tryptophan, l-arginine) impairs immune cell function.
  • These metabolic changes contribute to immune evasion by cancer.

Conclusions:

  • Metabolic pathways in the tumor microenvironment are critical regulators of anti-tumor immunity.
  • Targeting these metabolic vulnerabilities presents a promising strategy for cancer immunotherapy.
  • Restoring immune cell function through metabolic intervention can enhance anti-cancer T cell responses.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...